HomeDMAA • NASDAQ
add
Drugs Made In America Acquisition Corp
Previous close
$10.55
Day range
$10.56 - $10.57
Year range
$10.04 - $10.57
Market cap
356.05M USD
Avg Volume
195.11K
P/E ratio
74.85
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.09M | 646.57% |
Net income | 212.96K | 176.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.14K | 354.26% |
Total assets | 239.92M | 43,456.35% |
Total liabilities | 247.18M | 30,966.04% |
Total equity | -7.26M | — |
Shares outstanding | 33.72M | — |
Price to book | -47.93 | — |
Return on assets | -2.19% | — |
Return on capital | 71.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 212.96K | 176.09% |
Cash from operations | -125.18K | -1.65% |
Cash from investing | 0.00 | — |
Cash from financing | 130.60K | 5.86% |
Net change in cash | 5.42K | 2,352.49% |
Free cash flow | -1.36M | -1,521.06% |
About
Founded
2024
Website